Andere talen Inari Medical, Inc.

Aandelen

NARI

US45332Y1091

Beurs gesloten - Nasdaq Andere beurzen 22:00:01 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
37,14 ^USD	-2,08%		-5,01%	-42,79%

02/04	Inari Medical, Inc. Benner benoemd tot Senior Vice President van de verkoop in de V.S.	CI
26/03	Sectorupdate: Financiële aandelen winnen in de late namiddag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Inari Medical to Announce First Quarter 2024 Financial Results	17/04
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report	11/04
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives	02/04
Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales	02/04
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care	01/04
Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600	01/04
Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 400 Health Care	01/04
Inari Medical, Inc.(NasdaqGS:NARI) dropped from S&P 400	01/04
Sector Update: Financial Stocks Gain Late Afternoon	26/03
Sector Update: Financial Stocks Rise Tuesday Afternoon	26/03
AppFolio to Join S&P MidCap 400, Inari Medical to Join S&P SmallCap 600; AppFolio Shares Rise	26/03
Sector Update: Tech Stocks Mixed Premarket Tuesday	26/03
Sector Update: Tech	26/03
AppFolio to Join S&P MidCap 400, Inari Medical to Join S&P SmallCap 600	26/03
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inari Medical, Inc.- NARI	19/03
Inari Medical Insider Sold Shares Worth $251,461, According to a Recent SEC Filing	14/03
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry	12/03
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry	12/03
Inari Medical Investigation: Kessler Topaz Meltzer & Check, LLP Investigates The Inari Medical, Inc. (NASDAQ: NARI) for Potential Securities Violations	12/03
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	11/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Inari Medical, Inc.

Aandelen

NARI

US45332Y1091

Andere talen

Filters